Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics Munich, |
RCV000995581 | SCV001149838 | pathogenic | MOGS-congenital disorder of glycosylation | 2018-11-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000995581 | SCV004676687 | uncertain significance | MOGS-congenital disorder of glycosylation | 2023-01-15 | criteria provided, single submitter | clinical testing | This variant is present in population databases (no rsID available, gnomAD 0.002%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 807445). This variant has not been reported in the literature in individuals affected with MOGS-related conditions. This sequence change creates a premature translational stop signal (p.Glu622*) in the MOGS gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 216 amino acid(s) of the MOGS protein. |